[An angiogenesis inhibitor: TNP-470].
Bailly
C
C
Laboratoire de pharmacologie antitumorale, Centre Oscar-Lambret, et U. 524 Inserm, place de Verdun, 59045 Lille Cedex.
Lansiaux
A
A
D020533:Angiogenesis Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D003510:Cyclohexanes; D005260:Female; D005909:Glioblastoma / Q000188:drug therapy; D006801:Humans; D008546:Melanoma, Experimental / Q000188:drug therapy; D051379:Mice; D000077609:O-(Chloroacetylcarbamoyl)fumagillol; D051381:Rats; D012717:Sesquiterpenes / Q000737:chemistry / Q000494:pharmacology*; D014410:Tumor Stem Cell Assay; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy
D020533:Angiogenesis Inhibitors; D000903:Antibiotics, Antineoplastic; D003510:Cyclohexanes; D012717:Sesquiterpenes; D000077609:O-(Chloroacetylcarbamoyl)fumagillol